Imris (IMRS)
News
| May 16 | MAKO Entangled in Lawsuits |
| May 15 | $IMRS Canaccord reiterates a 'buy' and $4.50 target on IMRS! http://stks.co/3pfG by porsche17000 |
| May 15 | Canaccord Genuity Adjusting Estimates on Imris Inc. (IMRS); Bookings and Margins Up Street Insider |
| May 14 | $IMRS No wonder Graves was buying stock in March! by porsche17000 |
| May 14 | $IMRS Neuroarm FDA filing ahead of schedule in July 2012. Gonna be firing on all cylinders again. Hospital spending getting back to normal. by porsche17000 |
| May 14 | $IMRS Super bullish going forward. Graves upbeat. Backlog growing. Revs to grow sequentially each Q this year. 2012 bookings $80-100M! by porsche17000 |
| May 14 | $IMRS Back order looks good, i assume its where it is now due to the delays but will double by years end? Not sure how this will trade now by GArgondizza |
| May 14 | $IMRS http://stks.co/3ozl by GArgondizza |
| May 14 | IMRIS Reports First Quarter 2012 Financial Results PR Newswire |
| May 14 | $IMRS 10,000 shares bring it down .22? Really? by GArgondizza |
| May 08 | New Milestones In Visius Surgical Theatre By Imris PR Newswire |
| May 07 | IMRIS To Hold First Quarter 2012 Results Conference Call And 2012 Annual General Meet... |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Medical Instruments & Supplies
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Imris is down 56.99% over the last year vs S&P 500 Total Return up 1.18%, Strategic Diagnostics down 15.28%, and STAAR Surgical Company up 50.22%.
- IMRS Total Returns
- ^SPXTR Total Returns
- SDIX Total Returns
- STAA Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these IMRS related companies
Pro Strategies Featuring IMRS
Did Imris make it into our Pro Portfolio Strategies?
IMRS Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other IMRS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IMRS | 3.17 | +0.05 | +1.60% | 142.68M |
| IMOS | 13.17 | +0.58 | +4.61% | 338.92M |
| IMO | 41.35 | +0.91 | +2.25% | 34.28B |
| IMN | 5.71 | +0.16 | +2.88% | 212.73M |
| IDSA | 5.13 | -0.02 | -0.39% | 35.74M |
| IDRA | 1.00 | -0.02 | -1.96% | 27.64M |
| IDN | 1.64 | -0.09 | -5.07% | 47.44M |
| IDIX | 9.41 | -0.27 | -2.79% | 1.041B |
| IDI | 1.85 | -0.03 | -1.60% | 38.59M |
| IDCC | 25.28 | +0.14 | +0.56% | 1.134B |
